Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update | ||
By: GlobeNewswire - 24 Apr 2024 | Back to overview list |
|
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will report its first quarter 2024 financial results and provide a business update on May 9, 2024, at 7:00 am Eastern Time. Investors who would like to discuss the financial results or business update after the earnings release has been issued are invited to contact the company at IR@chemomab.com. About Chemomab Therapeutics Ltd. Contacts: Media and Investors: |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |